Company Data
Mineralys Therapeutics Inc.
Ticker
MLYS
Current Price
$43.05 2.11%
Market Cap
$2.9B
Price Target
Refer to Report
Volume
1.7M
52wk Range
$8.241 - $42.71
Overview
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.